Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: A Japanese multicenter clinical trial

Therapeutic Apheresis and Dialysis

Volumn 10, Issue 1, 2006, Pages 32-41

  Tasaki, Hiromi ^a   Yamashita, Kazuhito ^a   Saito, Yasushi ^b   Bujo, Hideaki ^b   Daida, Hiroyuki ^c   Mabuchi, Hiroshi ^d   Tominaga, Yoshihiro ^e   Matsuzaki, Masunori ^f   Fukunari, Kenichi ^g   Nakazawa, Ryoichi ^h   Tsuji, Masahiro ⁱ   Kawade, Yasumasa ^j   Yamamoto, Shigeo ^k   Ueda, Yukio ^l   Takayama, Kimihiro ^m  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

^e NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^f YAMAGUCHI UNIVERSITY   (Japan)

^g Shin Koga Hospital   (Japan)

^h Tokatsu Clinic Hospital   (Japan)

ⁱ Hokkaido Social Insurance Hospital   (Japan)

^j Central Clinic   (Japan)

^k KANSAI ROSAI HOSPITAL   (Japan)

^l Komatsu Municipal Hospital   (Japan)

^m Okazaki City Hospital   (Japan)

more..

Author keywords

Dextran sulfate cellulose column; Hemoperfusion; Low density lipoprotein apheresis

Indexed keywords

LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; APHERESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EVALUATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HEMOPERFUSION; HUMAN; JAPAN; LIPOPROTEIN BLOOD LEVEL; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BLOOD COMPONENT REMOVAL; CORONARY DISEASE; FEMALE; HEMOPERFUSION; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEIN(A); LIPOPROTEINS, LDL; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 33644985124     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2006.00315.x     Document Type: Article

References (28)

1. Bambauer R Schiel R Latza R Low-density lipoprotein apheresis: an overview Ther Apher Dial 2003 7 382 90
2. Gordon BR Kelsey SF Dau PC et al. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system Am J Cardiol 1998 81 407 11
3. Mabuchi H Koizumi J Shimizu M et al. on behalf of Hokuriku-FH-LDL- Apheresis Study Group. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia Am J Cardiol 1998 82 1489 95
4. Nishimura S Sekiguchi M Kano T et al. Effects of intensive lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS) Atherosclerosis 1999 144 409 17
5. Kroon AA Aengevaeren WR van der Werf T et al. on behalf of the LDL-apheresis atherosclerosis regression study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis Circulation 1996 93 1826 35
6. Tasaki H Low-density lipoprotein apheresis in the prevention of recurrent coronary heart disease: a review Ther Apher Dial 2003 7 408 12
7. Drager LJ Julius U Kraenzle K et al. DALI-the first human whole-blood low-density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical results Eur J Clin Invest 1998 28 944 1002
8. Bosch T Lennertz A Kordes B Samtleben W Low density lipoprotein hemoperfusion by direct adsorption of lipoproteins from whole blood (DALI apheresis): clinical experience from a single center Ther Apher 1999 3 209 13
9. Jansen M Banyai S Schmaldienst S et al. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolemia Wien Klin Wochenschr 2000 112 61 9
10. Otto C Kern P Bambauer R Kallert S Schwandt P Parhofer KG Efficacy and safety of a new whole-blood low-density lipoprotein apheresis system (Liposorber D) in severe hypoercholesterolemia Artif Organs 2003 27 1116 22
11. Tielemans C Madhoun P Lenaers M Schandene L Goldman M Vanherwegheim JL Anaphylactoid reactions during hemodialysis on AN 69 membranes in patients receiving ACE inhibitors Kidney Int 1990 38 982 4
12. Kobayashi A Nakatani M Furuyoshi S Tani N In vitro evaluation of dextran sulfate cellulose beads for whole blood infusion low-density lipoprotein-hemoperfusion Ther Apher 2002 6 365 71
13. Tasaki H Nakashima Y Nandate H Yashiro A Kawashima T Kuroiwa A Comparison of serum of lipid values in variant angina pectoris and fixed coronary artery disease with normal subjects Am J Cardiol 1989 63 1441 5
14. Abe K Yoshimura Y Sekine T Maeda S Yamashita S Noma A Fully mechanized latex immunoassay for serum lipoprotein(a) Clin Chim Acta 1994 225 105 13
15. Sekiguchi M [Ion-selective electrode method.] Kensa To Gijutsu 1989 17 1167 72 (in Japanese.)
16. Moellering H Gruber W Determination of citrate with citrate lyase Anal Biochem 1966 17 369 76
17. Mabuchi H Michishita I Takeda M et al. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis) Atherosclerosis 1987 68 19 25
18. Schmaldienst S Banyai S Stulnig TM et al. Prospective randomized cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolemia Atherosclerosis 2000 151 493 9
19. Tasaki H Tsuda Y Yamashita K Nakashima Y Removal of plasma fibrinogen by LDL apheresis Jap J Apheresis 1997 16 263 4
20. Assogba U Lepage S Bruckert E et al. Blood antioxidants (vitamin E and beta-carotene) in long-term low-density lipoprotein apheresis Clin Chim Acta 1995 235 147 57
21. Uauy R Zwiener RJ Phillips MJ Petruska ML Bilheimer DW Treatment of children with homozygous familial hypercholesterolemia: safety and efficacy of low-density lipoprotein apheresis J Pediatr 1992 120 892 8
22. Pascual M Blanc E Schifferli JA Complement activation by LDL-apheresis using dextran sulfate Nephrol Dial Transplant 1995 10 1476 7
23. Riesen WF Experience with low-density lipoprotein apheresis by polyclonal and monoclonal anti-apoliprotein B antibodies and by dextran sulfate cellulose Curr Stud Hematol Blood Transf 1990 57 208 19
24. Bambauer R Schiel R Latza R Low density lipoprotein apheresis in treatment of hyperlipidemia: experience with four different technologies Ther Apher 2000 4 213 17
25. Bosch T Direct adsorption of lipoproteins from whole blood by DALI apheresis: technique and effects Ther Apher 2001 5 239 43
26. Otto C Geiss HC Laubach E Schwandt P Effects of direct adsorption of lipoproteins apheresis on lipoproteins, low-density lipoprotein subtypes, and hemorheology in hypercholesterolemic patients with coronary artery disease Ther Apher 2002 6 130 5
27. Hershcovici T Schechner V Orlin J Harell D Beigel Y Effect of different LDL-apheresis methods on parameters involved in atherosclerosis J Clin Apheresis 2004 19 90 7
28. Bosch T Lennertz A Schenzle D Drager J Direct adsorption of lipoproteins (DALI) study group Direct adsorption of low-density lipoprotein and lipoprotein (a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis J Clin Apheresis 2002 17 161 9